Dr. Michael C. Schrader, MD, PhD

Dr. Schrader practices at UCSF Medical Group Business Services in San Francisco, California.

Dr. Schrader's NPI, 1225140742, was assigned on August 31, 2006. Dr. Schrader graduated from University of Pittsburgh School of Medicine in 1992. Dr. Schrader holds California license G77672.

Dr. Schrader's primary practice is UCSF Medical Group Business Services, at 521 Parnassus Ave, San Francisco, CA 94131 in San Francisco County. The practice phone is (415) 379-2900.

Dr. Schrader's primary practice is UCSF Medical Group Business Services in San Francisco, California. Dr. Schrader is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Schrader to 4 more hospitals, 3 group practices and clinics, 2 home health agencies and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schrader practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Schrader's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Schrader is board certified in internal medicine by the American Board of Internal Medicine. Dr. Schrader is licensed in California.

Dmand AI lists acid reflux, aneurysm, anxiety, arthritis, asthma, atrial fibrillation and flutter, bipolar disorder and cardiomyopathy among the conditions Dr. Schrader treats.

CMS data shows 1,330 Medicare services from Dr. Schrader across 13 procedure codes in 2024, for 371 Medicare patients. Medicare paid $126,722 for them. Every service was in an office.

CMS counts 371 Medicare patients who saw Dr. Schrader in 2024. The largest group is 75 to 84, with 185 patients. 75% of them have high cholesterol, and 59% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schrader's median patient age at 69, with 40% women.

In 2024, Dr. Schrader wrote 5,476 Medicare Part D claims for 562 patients. 87% of them were for generic drugs. CMS names the drug for 4,718 of them, across 98 drugs with 11 or more claims each, at $327,302 in total drug cost. In 2023, CMS named 4,991 claims across 107 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Schrader for performance year 2024, reported through an alternative payment model (APM). Dr. Schrader accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schrader as offering telehealth.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 108 papers to Dr. Schrader, published from 2008 to 2025. 2022 was the busiest year, with 9. The most frequent topics are Peroxisomes, Membrane Proteins and Mitochondria. Dr. Schrader has published most often in Urologe A. Dr. Schrader's most frequent co-authors are Mislen Stol Bauer, MD, David M. Eckmann, MD and Joseph Gerard Gleeson, MD.

CMS Open Payments shows 82 general payments to Dr. Schrader from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $438.

Dmand AI lists 1 award for Dr. Schrader, most recently CMS Stage 1 EHR in 2012.

Dr. Schrader graduated from University of Pittsburgh School of Medicine in 1992. Dr. Schrader is a member of ACP and San Francisco Marin Medical Society.

Dr. Schrader is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.